ArticleCellular and molecular life sciences : CMLS2026
Mettl3-mediated m6A disruption of olfactory bulb glutamatergic metabolism homeostasis via the Wnt pathway in aging leads to olfactory dysfunction.
Article in Cellular and molecular life sciences : CMLS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Olfactory dysfunction not only diminishes quality of life but also serves as an early biomarker for neurodegenerative diseases. However, the molecular mechanisms underlying age-related olfactory dysfunction remain poorly understood. In this study, we profiled the dynamics of m6A epitranscriptomics in mouse olfactory bulbs (OBs) throughout postnatal development, adulthood, and aging, revealing the dynamic remodeling of m6A methylation during the aging process. Our findings indicate that m6A modifications regulate various physiological processes in a stage-specific manner. Notably, in aged OBs, m6A methylation is enriched in genes associated with the Wnt signaling pathway. Furthermore, we identified a Wnt pathway involving Wnt, Ror2, and Nkd1 that may contribute to disrupted glutamate metabolism responses linked to age-related alterations in glutamatergic neuron function. This disruption is accompanied by significant reductions in glutamate and its related metabolites, suggesting an imbalance in neurotransmitter levels and impaired mitochondrial function—factors that may lead to olfactory dysfunction. Additionally, we identified METTL3 as a key m6A methyltransferase that drives age-related declines in olfactory function. Conditional knockdown of Mettl3 in aged OBs restores both olfactory function and activity within glutamatergic neurons. Our study provides valuable insights into the m6A-mediated mechanisms governing OB aging and highlights potential therapeutic targets for mitigating neur odegenerative-associated olfactory deficits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.